Long Opportunity Emerges as Sangamo Leverages Gene Editing to Hemophilia …
Long Opportunity Emerges As Sangamo Leverages Gene Editing To Hemophilia …
Filed under: drug treatment news articles
I have no business relationship with any company whose stock is mentioned in this article. (More…) The odds of a … It might be more acceptable to patients than drug therapy, which can cost up to $ 40,000 per year and cause toxic side effects. At the …
Read more on Seeking Alpha
FDA Advisory Committee Recommends Accelerated Approval of Investigational …
Filed under: drug treatment news articles
28, 2012 — /PRNewswire/ — Janssen Research & Development, LLC (Janssen) today announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA), in a unanimous vote (18-0), agreed that the efficacy findings for …
Read more on Sacramento Bee
Empire Genomics Licenses First Known DNA Biomarker for Use in Determining …
Filed under: drug treatment news articles
The company offers a wide range of best in class products and services that are used to quantify genomic changes. The firm is a leader in the field of personalized medicine and helps clinicians, drug developers and researchers answer key questions in …
Read more on Sacramento Bee
Clinton releases road map for AIDS-free generation
Filed under: drug treatment news articles
WASHINGTON (AP) — In an ambitious road map for slashing the global spread of AIDS, the Obama administration says treating people sooner and more rapid expansion of other proven tools could help even the hardest-hit countries begin turning the tide of …
Read more on Boston.com